Implementation of a pharmacy-driven program to improve nasal mupirocin use

Am J Health Syst Pharm. 2011 Dec 1;68(23):2222, 2224, 2226, 2228. doi: 10.2146/ajhp110021.
No abstract available

MeSH terms

  • Administration, Intranasal
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Cross Infection
  • Humans
  • Mass Screening / methods
  • Medication Adherence
  • Mupirocin / administration & dosage
  • Mupirocin / therapeutic use*
  • Pharmacy Service, Hospital / organization & administration*
  • Staphylococcal Infections / diagnosis
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Mupirocin